PM360 2018 Innovative Startup MedBlox, Inc.

MedBlox, Inc.

Somchai Rice, Co-Founder & Chief Science Officer
s.rice@medblox.io

Physicians are spending 11.8 minutes directly interacting with a patient per visit, 8.3 minutes interacting with the electronic health record (EHR) system during the patient’s visit, and 10.6 minutes interacting with the EHR system outside of the patient’s visit. This results in 18.9 minutes spent on EHR, or 62% of a physician’s time, according to The Harris Poll conducted on behalf of Stanford Medicine. While wide adoption of EHR was supposed to lead to unshackled patient health information and more time with patients, instead patient-doctor interaction has decreased.

MedBlox seeks to overcome the current hurdles in EHR through improved (1) Interoperability; (2) Data security; (3) Lack of clear regulation; and (4) Availability. MedBlox is designed to fulfill the criteria necessary to increase interoperability, which includes a data exchange that can be open to everyone, and the ability to cut across borders. MedBlox-distributed ledger technology is designed to securely store, share, and sustain EHRs in a validated and certified manner—all while leaving the health record owner, the patient, in complete control. MedBlox ensures data security with complete anonymity and trust to ensure we all play a part in molding the next-generation of healthcare innovators. MedBlox has also designed a secured transfer of ownership process to account for the bulk transitions of data from a provider to patient.

The company was incorporated in July 2018. MedBlox has validated the platform for the architecture and continued development of standardized data feed/ingestion and is continuing app development. The platform is not currently on the market, but partnerships are projected to go live in early 2019.

Ads

You May Also Like

Pitfalls of Generic Drug Marketing

While many advertising agencies, companies, healthcare professionals, and consumers alike may not realize it, ...

Why Marketing Leadership Matters

Healthcare organizations are increasingly investigating and unleashing the power of intelligent digital technologies, using ...

Learning to Speak HEOR

As one formulary decision-maker told us: “Recent regulation guidance on FDAMA114 frees up pharma ...